Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lunar OI: Sex Differences and Compression Garment Effect on Orthostatic Intolerance
NCT06467825Recruiting
- Sponsor
- NASA
- Start
- Aug 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of furosemide in orthostatic intolerance (3 arms), sponsored by NASA. Primary endpoints: Plasma Volume, Tilt Tolerance Time and 2 more. Started Aug 2022; status: recruiting.
02
Drugs
furosemide
03
Conditions
orthostatic intolerance
Beyond the preview
Go deeper on NCT06467825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06467825.